Publication Year: 2020
-
Design and Characterization of a Novel Blood Collection and Transportation Device for Proteomic Applications
-
Assessment of Integrated Classifier’s Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2 Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
-
Use of Two Blood-Based Biomarker Tests in Series to Reclassify Risk of Indeterminate Pulmonary Nodules
-
Lung Nodule Integrated Classifier Biomarker: First Data with Real-World Clinical Use
-
Identification of Likely Malignant Indeterminate Pulmonary Nodules by Analysis of Autoantibodies Against Lung Cancer Associated Antigens
-
Real World Data: Importance of Monitoring Blood Based KRAS Mutations and Immune Status in Patients with advanced NSCLC
-
A proposal for score assignment to characterize biological processes from mass spectral analysis of serum
-
Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
-
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis
-
A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors